Just Published

Metformin Shows Promise in Schizophrenia Trial
news

July 23, 2025

A new study suggests metformin may boost cognition in schizophrenia by reviving brain metabolism and connectivity.
JCP
Early Ketamine Response Reduces Suicidal Events at 3 Months
Original Research

July 23, 2025

Patients whose suicidal ideation responded to ketamine treatment at 7 days after a suicidal crisis had 75% lower odds of experiencing suicidal events at 3 months.
, , , et al
Can Music Therapy Rewrite the Playbook on Dementia Care?
news

July 22, 2025

A new UK study finds that embedding personalized music therapy into daily dementia care may offer a safer alternative to psychotropics.
PCC
Reversible Cerebral Vasoconstriction Syndrome and Marijuana
Letter to the Editor

July 22, 2025

The authors raise awareness of a potential complication of extensive marijuana use.
, ,
When Are Tears Honest? It Depends.
news

July 21, 2025

Tears may seem sincere, but a global study shows we judge their honesty based on context, bias, and even our own personality.
JCP
Niacin-Induced Response in Early Psychosis
Original Research

July 21, 2025

The authors found that niacin-induced skin flushing response attenuation can serve as a valuable early marker for psychosis.
, , , et al

Explore
By Topic

View all topics
Addiction Anxiety Bipolar Disorder Depression (MDD) Movement Disorders Neurology Obsessive-Compulsive and Related Disorders Psychopharmacology Schizophrenia/Schizoaffective Disorders Tardive Dyskinesia

Front of Mind News

PAs Deliver Quality Care. But Evidence Remains Thin.

Recent Features

The Journal of Clinical Psychiatry

The Journal of Clinical Psychiatry is a leader in peer-reviewed articles on mental health topics for psychiatrists and medical professionals.

View JCP Articles
JCP
How Do We Get Ketamine Safety Right? Three Questions from a Clinical Service
Commentary

July 16, 2025

The authors discuss three unanswered questions regarding ketamine, which relate to suicidality during administration, patients with substance use disorders, and REMS monitoring.
, , , et al
JCP
Klotho and Matrix Metalloproteinase-9 Levels and Their Association with Inhibitory Dyscontrol in Adolescents with First-Episode Major Affective Disorders
Original Research

July 16, 2025

Adolescents with bipolar disorder and those with MDD had significantly lower Klotho levels compared with the control group; those with bipolar disorder had the highest MMP-9 levels, followed by…
, , , et al

The Primary Care Companion for CNS Disorders

The Primary Care Companion for CNS Disorders seeks to advance the clinical expertise of primary care physicians and other health care professionals who treat patients with mental and neurologic illnesses.

View PCC Articles
PCC
Bipolar Disorder Preceding PTC Diagnosis
Case Report

July 17, 2025

This case highlights the challenges of managing bipolar disorder in the context of an incidental diagnosis of papillary thyroid carcinoma
,
PCC
Safety of ECT in Severe Thrombocytopenia
Case Report

July 15, 2025

Due to the lack of published guidelines, psychiatrists may face challenges weighing risks and benefits of ECT in patients with severe thrombocytopenia.
, , , et al
CME Logo

Recent CME Institute Activities

2025 Manuscript Peer Review for Physicians Postgraduate Press, Inc. (The Journal of Clinical Psychiatry | The Primary Care Companion for CNS Disorders)

2025 Manuscript Peer Review for Physicians Postgraduate Press, Inc. (The Journal of Clinical Psychiatry | The Primary Care Companion for CNS Disorders)
Evaluating the Old and New in Alzheimer’s Disease: Today’s Options for Improving Diagnosis and Treatment

Evaluating the Old and New in Alzheimer’s Disease: Today’s Options for Improving Diagnosis and Treatment
Alzheimer's Disease: New Paths to Treatment

Alzheimer’s Disease: New Paths to Treatment
Staying Up to Date in Perinatal Depression: Pathophysiology and Treatment Research

Staying Up to Date in Perinatal Depression: Pathophysiology and Treatment Research
Neuropsychiatric Complications of Parkinson’s Disease Psychosis

Neuropsychiatric Complications of Parkinson’s Disease Psychosis
Assessing Progress in FSHD Treatment Options: Unraveling Challenges and Measuring Outcomes

Assessing Progress in FSHD Treatment Options: Unraveling Challenges and Measuring Outcomes

Read articles from ASCP Corner

ASCP Corner

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe